The decision by one of the world’s leading museums could spur other institutions to turn down philanthropy from the family behind OxyContin.
ELIZABETH A. HARRIS, NY Times: Art & Design
Wed, 05/15/2019 - 9:01am
The decision by one of the world’s leading museums could spur other institutions to turn down philanthropy from the family behind OxyContin.